Cormorant Asset Management, LP is an investment firm that reports beneficial ownership of shares in BRIGHT MINDS BIOSCIENCES INC. (DRUG) and 1 other company under U.S. securities law. It has submitted 3 SEC insider filings since 2024, most recently in November 2024.
Every role Cormorant Asset Management, LP has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
BRIGHT MINDS BIOSCIENCES INC. (DRUG)2 filingsBioAge Labs, Inc. (BIOA)1 filingUpdated Aug 30, 2026
Cormorant Asset Management, LP files SEC Form 4 reports at BRIGHT MINDS BIOSCIENCES INC. (DRUG). 3 SEC Form 4 filings on record, most recently on 6 November 2024. Most recent open-market trade: bought $4.00M of DRUG on 6 November 2024. Lifetime open-market purchases: $15.33M. Historical track record: 5/5 stars across 13 tracked purchases.
Every recent SEC Form 4 transaction Cormorant Asset Management, LP has reported, most recent first.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 13 |
| Purchases with forward-return data | 13 |
| 30-day win rate | 92% |
| 90-day win rate | 23% |
| Avg 5-day return | +29.19% |
| Avg 30-day return | +15.69% |
| Avg 90-day return | -7.33% |
| Best 30-day return |
InsiderAlpha's records for Cormorant Asset Management, LP go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $1.18M (13 buys totaling $15.33M). The largest single buy on record is $8.10M of BIOA in 2024. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Cormorant Asset Management, LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Cormorant Asset Management, LP is an investment firm of BRIGHT MINDS BIOSCIENCES INC. (DRUG). InsiderAlpha holds 3 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 6 November 2024, one of 3 filings going back to 2024.
Recorded transactions: 13 open-market purchases ($15.33M) and 0 open-market sales across all tracked filings.
Across 13 tracked purchases, Cormorant Asset Management, LP averaged +15.7% avg 30-day return with a 92% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$DRUG BRIGHT MINDS BIOSCIENCES INC.7.2K shares @ $24.03$172K
| +37.53% |